Charles Elliott Sigal, Director at Vir Biotechnology, Inc. (VIR), bought 2,500 shares at $24.96 ($62K) on 2023-01-05, disclosed to the SEC on 2023-01-09.
Open-market purchase of $62k VIR by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| ADAP | BUY | 2016-05-19 | $23K | — | Filing → |
| ADAP | BUY | 2016-05-18 | $69K | — | Filing → |